11065

537291

NATHBIOGEN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NATH BIO-GENES (I) LTD Share Price Today

NATH BIO-GENES (I) LTD is currently trading at ₹167.15, down by ₹1.87 from the previous close. The stock touched an intraday high of ₹173.00 and a low of ₹166.81 during the latest trading session. Over the past one year, NATH BIO-GENES (I) LTD has delivered a loss of 19.13%, while the stock has gained 1.88% in the last one month.

NATH BIO-GENES (I) LTD performance

Today’s low Today’s high
₹ 166.81 ₹ 173.00
₹ 171.53
52 week low 52 week high
₹ 126.15 ₹ 238.69
₹ 171.53
Open Price ₹ 169.00
Prev. Close ₹ 169.02
Volume (Shares) 17829.00
Total traded value ₹ 30.58
Upper Circuit ₹ 202.82
Lower Circuit ₹ 135.22
info

Investment Returns

Over 1 Month 1.88% Over 3 Months 15.34% Over 6 Months 8.55% Over 1 Year -19.13%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NATH BIO-GENES (I) LTD fundamentals


  • Market cap (Cr) 326.00
  • P/E Ratio (TTM) 7.23
  • Beta 0.85
  • Book Value / share 362.75
  • Return on equity 6.69%
  • EPS (TTM) 20.52
  • Dividend yield 1.18%
  • Net profit/quarter (Cr) 3.79
info icon alternate text
  • Market cap (Cr) 325.00
  • P/E Ratio (TTM) 7.23
  • Beta 0.70
  • Book Value / share 362.75
  • Return on equity 6.69%
  • EPS (TTM) 20.52
  • Dividend yield 1.18%
  • Net profit/quarter (Cr) 3.79
info icon alternate text

NATH BIO-GENES (I) LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 45.69
Operating Expense 43.04
Net Profit 3.79
Net Profit Margin (%) 8.29
Earnings Per Share (EPS) 2.17
EBITDA 10.25
Effective Tax Rate (%) 39.74
Particulars DEC 2025 (Values in Cr)
Revenue 65.96
Operating Expense 62.28
Net Profit 7.23
Net Profit Margin (%) 10.96
Earnings Per Share (EPS) 3.85
EBITDA 13.26
Effective Tax Rate (%) 10.74
Particulars SEP 2025 (Values in Cr)
Revenue 39.77
Operating Expense 36.86
Net Profit 4.20
Net Profit Margin (%) 10.56
Earnings Per Share (EPS) 2.21
EBITDA 9.12
Effective Tax Rate (%) 13.22
Particulars JUN 2025 (Values in Cr)
Revenue 280.17
Operating Expense 245.13
Net Profit 38.21
Net Profit Margin (%) 13.63
Earnings Per Share (EPS) 20.06
EBITDA 40.66
Effective Tax Rate (%) 1.79
Particulars MAR 2025 (Values in Cr)
Revenue 49.37
Operating Expense 48.62
Net Profit 4.71
Net Profit Margin (%) 9.54
Earnings Per Share (EPS) 2.12
EBITDA 7.22
Effective Tax Rate (%) 13.12
Particulars MAR 2026 (Values in Cr)
Revenue 431.60
Operating Expense 396.32
Net Profit 44.43
Net Profit Margin (%) 10.29
Earnings Per Share (EPS) 23.42
EBITDA 66.36
Effective Tax Rate (%) 9.51
Particulars MAR 2025 (Values in Cr)
Revenue 362.31
Operating Expense 323.45
Net Profit 42.14
Net Profit Margin (%) 11.63
Earnings Per Share (EPS) 22.00
EBITDA 57.55
Effective Tax Rate (%) 4.48
Particulars MAR 2024 (Values in Cr)
Revenue 332.62
Operating Expense 294.60
Net Profit 40.18
Net Profit Margin (%) 12.07
Earnings Per Share (EPS) 21.63
EBITDA 51.03
Effective Tax Rate (%) 5.04
Particulars MAR 2023 (Values in Cr)
Revenue 301.29
Operating Expense 265.53
Net Profit 35.17
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 18.50
EBITDA 49.44
Effective Tax Rate (%) 3.16
Particulars MAR 2022 (Values in Cr)
Revenue 278.36
Operating Expense 254.64
Net Profit -67.17
Net Profit Margin (%) -24.13
Earnings Per Share (EPS) -35.43
EBITDA -49.53
Effective Tax Rate (%) -6.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 339.08
ROE % 6.15
ROCE % 6.86
Total Debt to Total Equity 0.19
EBITDA Margin 15.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 320.94
ROE % 6.70
ROCE % 7.23
Total Debt to Total Equity 0.18
EBITDA Margin 16.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.61
ROE % 6.28
ROCE % 7.03
Total Debt to Total Equity 0.18
EBITDA Margin 16.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.16
ROE % 4.38
ROCE % 5.64
Total Debt to Total Equity 0.17
EBITDA Margin 14.04
Particulars MAR 2013 (Values in Cr)
Book Value / Share 35.91
ROE % 22.77
ROCE % 23.41
Total Debt to Total Equity 0.29
EBITDA Margin 14.87
Particulars MAR 2025 (Values in Cr)
Book Value / Share 341.33
ROE % 6.69
ROCE % 7.25
Total Debt to Total Equity 0.17
EBITDA Margin 15.92
Particulars MAR 2024 (Values in Cr)
Book Value / Share 321.33
ROE % 6.79
ROCE % 7.31
Total Debt to Total Equity 0.18
EBITDA Margin 16.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.70
ROE % 6.31
ROCE % 7.06
Total Debt to Total Equity 0.18
EBITDA Margin 16.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.19
ROE % 4.12
ROCE % 5.32
Total Debt to Total Equity 0.17
EBITDA Margin 14.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 322.71
ROE % 9.51
ROCE % 9.74
Total Debt to Total Equity 0.15
EBITDA Margin 22.25
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 88.89
Total Assets 1026.20
Total Liabilities 1026.20
Total Equity 644.38
Share Outstanding 1
Price to Book Ratio 0.43
Return on Assets (%) 3.76
Return on Capital (%) 5.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 77.40
Total Assets 880.23
Total Liabilities 880.23
Total Equity 609.91
Share Outstanding 1
Price to Book Ratio 0.54
Return on Assets (%) 4.50
Return on Capital (%) 5.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.99
Total Assets 792.79
Total Liabilities 792.79
Total Equity 573.15
Share Outstanding 1
Price to Book Ratio 0.47
Return on Assets (%) 4.41
Return on Capital (%) 5.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 739.48
Total Liabilities 739.48
Total Equity 541.92
Share Outstanding 1
Price to Book Ratio 0.75
Return on Assets (%) -9.11
Return on Capital (%) -10.61
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 158.28
Total Liabilities 158.28
Total Equity 57.47
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 7.42
Return on Capital (%) 15.49
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 87.63
Total Assets 1016.86
Total Liabilities 1016.86
Total Equity 648.66
Share Outstanding 1
Price to Book Ratio 0.43
Return on Assets (%) 4.14
Return on Capital (%) 5.55
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 75.50
Total Assets 877.08
Total Liabilities 877.08
Total Equity 610.65
Share Outstanding 1
Price to Book Ratio 0.54
Return on Assets (%) 4.58
Return on Capital (%) 5.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.98
Total Assets 792.97
Total Liabilities 792.97
Total Equity 573.35
Share Outstanding 1
Price to Book Ratio 0.47
Return on Assets (%) 4.43
Return on Capital (%) 5.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.16
Total Assets 739.53
Total Liabilities 739.53
Total Equity 541.96
Share Outstanding 1
Price to Book Ratio 0.75
Return on Assets (%) -9.10
Return on Capital (%) -10.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.21
Total Assets 789.50
Total Liabilities 789.50
Total Equity 613.27
Share Outstanding 1
Price to Book Ratio 0.93
Return on Assets (%) 7.05
Return on Capital (%) 7.86
Particulars MAR 2025 (Values in Cr)
Net Income 40.58
Cash from Operations 18.66
Cash from Investing -3.96
Cash from Financing -2.12
Net change in Cash 11.48
Free Cash Flow 26.58
Particulars MAR 2024 (Values in Cr)
Net Income 41.56
Cash from Operations 74.93
Cash from Investing -27.40
Cash from Financing -7.77
Net change in Cash 39.41
Free Cash Flow 101.70
Particulars MAR 2023 (Values in Cr)
Net Income 36.16
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.43
Cash from Operations 19.92
Cash from Investing -19.85
Cash from Financing -22.23
Net change in Cash -25.03
Free Cash Flow 21.02
Particulars MAR 2013 (Values in Cr)
Net Income 12.29
Cash from Operations 14.76
Cash from Investing -20.76
Cash from Financing 5.74
Net change in Cash -0.81
Free Cash Flow 36.11
Particulars MAR 2025 (Values in Cr)
Net Income 44.12
Cash from Operations 27.88
Cash from Investing -4.05
Cash from Financing -10.62
Net change in Cash 12.12
Free Cash Flow 35.63
Particulars MAR 2024 (Values in Cr)
Net Income 42.12
Cash from Operations 75.06
Cash from Investing -27.39
Cash from Financing -9.80
Net change in Cash 37.51
Free Cash Flow 101.83
Particulars MAR 2023 (Values in Cr)
Net Income 36.31
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.38
Cash from Operations 19.92
Cash from Investing -19.86
Cash from Financing -22.23
Net change in Cash -25.04
Free Cash Flow 21.03
Particulars MAR 2021 (Values in Cr)
Net Income 56.75
Cash from Operations 1.41
Cash from Investing -10.28
Cash from Financing 16.40
Net change in Cash 7.23
Free Cash Flow 12.96
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD. 5165.35 49.11 24.36 124416.91 5038.00 6336.95
NESTLE INDIA LTD. 1375.85 77.95 51.44 265307.13 1085.00 1498.60
FOODS & INNS LTD. 53.88 14.29 0.70 396.19 45.00 128.79
HINDUSTAN UNILEVER LTD. 2167.55 33.44 10.44 509285.65 2023.05 2734.31
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
BRITANNIA INDUSTRIES LTD. 5165.35 48.57 26.80 124416.91 5038.00 6336.95
COLGATE PALMOLIVE LTD. 2078.90 42.08 35.69 56543.09 1781.60 2505.00
NESTLE INDIA LTD. 1375.85 76.95 49.97 265307.13 1085.00 1498.60
FOODS & INNS LTD. 53.88 12.65 0.69 396.19 45.00 128.79

NATH BIO-GENES (I) LTD shareholding pattern

Holding
54.16%
45.59%
0.22%
0.01%
13.78%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

NATH BIO-GENES (I) LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
171.53 1.48 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 168.20
  • 26 Days 169.00
  • 10 Days 169.00
  • 50 Days 165.90
  • 12 Days 169.20
  • 100 Days 162.00
  • 20 Days 169.40
  • 200 Days 163.90
167.07 PIVOT
First Support 164.15 First Resistance 169.35 Second Support 161.87 Second Resistance 172.27 Third Support 158.95 Third Resistance 174.55
RSI 46.73 ADX 9.02 MACD 0.26 Williams % R -88.41 Commodity Channel Index (CCI) -40.90
Date 2026-06-12 Week 6775.00 Same Day 8536.00 Month 11316.00
1 Year 0.85 3 Year 1.02
Over 1 Month
1.88% down
Over 1 Year
-19.13% down
Over 3 Months
15.34% down
Over 3 Years
-3.99% down
Over 6 Months
8.55% down
Over 5 Years
-16.20% down

NATH BIO-GENES (I) LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 2.0 Final 14 Aug 2025 Equity shares
09 Aug 2024 2.0 Final 09 Aug 2024 Equity shares
04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 2.0 Final 14 Aug 2025 Equity shares
09 Aug 2024 2.0 Final 09 Aug 2024 Equity shares
04 Jul 2023 2.0 Final 30 Jun 2023 Equity shares
23 Jun 2022 2.0 Final 25 Jun 2022 Equity shares
18 Aug 2021 2.0 Final 22 Aug 2021 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nath Bio-Genes (India) Ltd?

Answer Field

Nath Bio-Genes (India) Ltd share price is for NSE ₹ 167.15 & for BSE ₹ 169.00 as on Jun 16 2026 03:29 PM.

What is the Market Cap of Nath Bio-Genes (India) Ltd Share?

Answer Field

The market cap of Nath Bio-Genes (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 16 2026 03:29 PM.

What is the 52 Week High and Low of Nath Bio-Genes (India) Ltd?

Answer Field

The 52 Week High and Low of Nath Bio-Genes (India) Ltd for NSE is ₹ 238.69 and ₹ 126.15 and for BSE is ₹ 238.00 and ₹ 126.75.

What is 1 year return for Nath Bio-Genes (India) Ltd?

Answer Field

The 1 year returns on the stock has been -16.84%.

What is the P/E Ratio of Nath Bio-Genes (India) Ltd Share?

Answer Field

As on Jun 16 2026 03:29 PM the price-to-earnings (PE) ratio for Nath Bio-Genes (India) Ltd share is 7.23.

What is the PB ratio of Nath Bio-Genes (India) Ltd Share?

Answer Field

As on Jun 16 2026 03:29 PM, the price-to-book (PB) ratio for Nath Bio-Genes (India) Ltd share is 362.75.

How to Buy Nath Bio-Genes (India) Ltd Share?

Answer Field

You can trade in Nath Bio-Genes (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nath Bio-Genes (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Nath Bio-Genes (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nath Bio-Genes (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|